Shrestha Raj Kumar, Shrestha Dhruba, Kunwar Ajaya Jang, Thapa Sandeep, Shrestha Nipun, Dhoubhadel Bhim Gopal, Parry Christopher M
Siddhi Memorial Hospital, Bhimsensthan-7, Bhaktapur, Nepal.
Kathmandu Center for Genomics and Research Laboratory, Lalitpur, Nepal.
Trop Med Health. 2024 Apr 8;52(1):30. doi: 10.1186/s41182-024-00595-3.
There is a lack of data on the characteristics of overlap between acquired antimicrobial resistance and virulence factors in Klebsiella pneumoniae in high-risk settings, especially with the inclusion of surveillance isolates along with the clinical. We investigated K. pneumoniae isolates, from a neonatal intensive care unit (NICU) in Nepal, for the presence of both accessory virulence factors and acquired antimicrobial resistance.
Thirty-eight clinical and nineteen surveillance K. pneumoniae isolates obtained between January 2017 and August 2022 in the NICU of Siddhi Memorial Hospital, Bhaktapur, Nepal were investigated with antimicrobial susceptibility testing, PCR-based detection of β-lactamases and virulence factors, and genetic similarity by ERIC-PCR.
K. pneumoniae was found positive in 37/85 (43.5%) blood culture-positive neonatal bloodstream infections, 34/954 (3.6%) patient surveillance cultures, and 15/451 (3.3%) environmental surveillance samples. Among 57 isolates analyzed in this study, we detected multidrug resistance in 37/57 (64.9%), which was combined with at least one accessory virulence factor in 21/37 (56.8%). This overlap was mostly among β-lactamase producing isolates with accessory mechanisms of iron acquisition. These isolates displayed heterogenous ERIC-PCR patterns suggesting genetic diversity.
The clinical significance of this overlap between acquired antimicrobial resistance and accessory virulence genes in K. pneumoniae needs further investigation. Better resource allocation is necessary to strengthen infection prevention and control interventions in resource-limited settings.
在高风险环境中,关于肺炎克雷伯菌获得性抗菌药物耐药性与毒力因子重叠特征的数据匮乏,尤其是纳入监测分离株以及临床分离株的情况。我们调查了尼泊尔一家新生儿重症监护病房(NICU)的肺炎克雷伯菌分离株,以确定其是否同时存在辅助毒力因子和获得性抗菌药物耐药性。
对2017年1月至2022年8月期间在尼泊尔巴克塔普尔市悉地纪念医院NICU获得的38株临床肺炎克雷伯菌分离株和19株监测分离株进行了抗菌药物敏感性测试、基于PCR的β-内酰胺酶和毒力因子检测以及ERIC-PCR基因相似性分析。
在37/85(43.5%)血培养阳性的新生儿血流感染、34/954(3.6%)患者监测培养物以及15/451(3.3%)环境监测样本中发现肺炎克雷伯菌呈阳性。在本研究分析的57株分离株中,我们检测到37/57(64.9%)存在多重耐药性,其中21/37(56.8%)与至少一种辅助毒力因子同时存在。这种重叠主要发生在产生β-内酰胺酶且具有铁获取辅助机制的分离株中。这些分离株显示出异质性ERIC-PCR模式,表明存在遗传多样性。
肺炎克雷伯菌获得性抗菌药物耐药性与辅助毒力基因之间这种重叠的临床意义需要进一步研究。在资源有限的环境中,需要更好地分配资源以加强感染预防和控制干预措施。